| Gregory C Collins, MD | |
|
1301 Atlantic Ave, Atlantic City, NJ 08401-7247 | |
| (609) 572-0000 | |
| (609) 572-0039 |
| Full Name | Gregory C Collins |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 33 Years |
| Location | 1301 Atlantic Ave, Atlantic City, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043229065 | NPI | - | NPPES |
| 6447503 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA05975100 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atlanticare Regional Medical Center | Atlantic city, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prohealth Urgent Care Medicine Of New Jersey Llp | 6002178647 | 96 |
| Southern Jersey Family Medical Centers, Inc | 0547170763 | 33 |
News Archive
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Data supporting the need for better recognition of iron deficiency will be presented this week at the United European Gastroenterology Week Congress in Berlin. Iron deficiency is frequently under-diagnosed, resulting in increased hospitalisation, reduced quality of life and higher death rates in patients with comorbid conditions. The WHO has estimated that iron deficiency causes the loss of 48,225 disability-adjusted life-years worldwide, more than is seen with lung cancer.
Royal Philips today announced a new initiative with Massachusetts Institute of Technology to allow health care researchers to tap into one of the largest data sources available for research into critical care.
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
› Verified 8 days ago
| Entity Name | Southern Jersey Family Medical Centers, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568473973 PECOS PAC ID: 0547170763 Enrollment ID: O20040917000774 |
News Archive
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Data supporting the need for better recognition of iron deficiency will be presented this week at the United European Gastroenterology Week Congress in Berlin. Iron deficiency is frequently under-diagnosed, resulting in increased hospitalisation, reduced quality of life and higher death rates in patients with comorbid conditions. The WHO has estimated that iron deficiency causes the loss of 48,225 disability-adjusted life-years worldwide, more than is seen with lung cancer.
Royal Philips today announced a new initiative with Massachusetts Institute of Technology to allow health care researchers to tap into one of the largest data sources available for research into critical care.
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
› Verified 8 days ago
| Entity Name | Medexpress Urgent Care - New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205183894 PECOS PAC ID: 6103076526 Enrollment ID: O20121022000045 |
News Archive
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Data supporting the need for better recognition of iron deficiency will be presented this week at the United European Gastroenterology Week Congress in Berlin. Iron deficiency is frequently under-diagnosed, resulting in increased hospitalisation, reduced quality of life and higher death rates in patients with comorbid conditions. The WHO has estimated that iron deficiency causes the loss of 48,225 disability-adjusted life-years worldwide, more than is seen with lung cancer.
Royal Philips today announced a new initiative with Massachusetts Institute of Technology to allow health care researchers to tap into one of the largest data sources available for research into critical care.
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
› Verified 8 days ago
| Entity Name | Prohealth Urgent Care Medicine Of New Jersey Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477927754 PECOS PAC ID: 6002178647 Enrollment ID: O20180320001992 |
News Archive
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Data supporting the need for better recognition of iron deficiency will be presented this week at the United European Gastroenterology Week Congress in Berlin. Iron deficiency is frequently under-diagnosed, resulting in increased hospitalisation, reduced quality of life and higher death rates in patients with comorbid conditions. The WHO has estimated that iron deficiency causes the loss of 48,225 disability-adjusted life-years worldwide, more than is seen with lung cancer.
Royal Philips today announced a new initiative with Massachusetts Institute of Technology to allow health care researchers to tap into one of the largest data sources available for research into critical care.
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
› Verified 8 days ago
| Entity Name | Medexpress Urgent Care - Northern New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487185369 PECOS PAC ID: 4183965122 Enrollment ID: O20190401001534 |
News Archive
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Data supporting the need for better recognition of iron deficiency will be presented this week at the United European Gastroenterology Week Congress in Berlin. Iron deficiency is frequently under-diagnosed, resulting in increased hospitalisation, reduced quality of life and higher death rates in patients with comorbid conditions. The WHO has estimated that iron deficiency causes the loss of 48,225 disability-adjusted life-years worldwide, more than is seen with lung cancer.
Royal Philips today announced a new initiative with Massachusetts Institute of Technology to allow health care researchers to tap into one of the largest data sources available for research into critical care.
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory C Collins, MD 1 N White Horse Pike, Hammonton, NJ 08037-1875 Ph: (609) 567-0200 | Gregory C Collins, MD 1301 Atlantic Ave, Atlantic City, NJ 08401-7247 Ph: (609) 572-0000 |
News Archive
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. as its February 2010 "Stock to Study" and C.R. Bard, Inc. as its February 2010 "Undervalued Stock" for investors' informational and educational use.
Data supporting the need for better recognition of iron deficiency will be presented this week at the United European Gastroenterology Week Congress in Berlin. Iron deficiency is frequently under-diagnosed, resulting in increased hospitalisation, reduced quality of life and higher death rates in patients with comorbid conditions. The WHO has estimated that iron deficiency causes the loss of 48,225 disability-adjusted life-years worldwide, more than is seen with lung cancer.
Royal Philips today announced a new initiative with Massachusetts Institute of Technology to allow health care researchers to tap into one of the largest data sources available for research into critical care.
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.
Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.
› Verified 8 days ago
Dr. Nikhil Chinmaya, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave Fl 8, Atlantic City, NJ 08401 Phone: 609-441-8146 | |
Sacha Florestal Charles, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8146 | |
Dr. William B Adams, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-345-4000 | |
Magdalena Szulc, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8146 Fax: 609-441-8002 | |
Manoj K Patel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8074 | |
Saleena Malik, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 2015 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-449-4391 |